Analyst Ratings for Proteostasis Therapeutics (PTI)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/14/2020 | Piper Sandler | Edward A. Tenthoff | Upgrade | Overweight (Neutral) |
2.00 (3.00) |
1.19 (1.11) |
-6.72% | Details |
| 11/7/2018 | Cantor Fitzgerald » Updated 1/29/2020 |
Kristen Kluska | New Coverage | Overweight (N/A) |
4.00 (N/A) |
6.93 (1.11) |
-83.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
